Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists

British Journal of Pharmacology

Volumn 148, Issue 5, 2006, Pages 640-647

  Kuo, Dong Yih ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anorectic agent; Brain; Food intake; Insulin; Orexigenic peptide

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; INSULIN; NEUROPEPTIDE Y; QUINPIROLE; SODIUM CHLORIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEEDING BEHAVIOR; FOOD INTAKE; HYPERPHAGIA; INSULIN TREATMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; TREATMENT RESPONSE;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; APPETITE DEPRESSANTS; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE AGONISTS; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; EATING; FEEDING BEHAVIOR; HORMONE REPLACEMENT THERAPY; HYPERPHAGIA; HYPOTHALAMUS; INJECTIONS; INSULIN; MALE; NEUROPEPTIDE Y; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 33745611450     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706754     Document Type: Article

References (38)

1. ALLEN, J.M., YEATS, J.C., ADRIAN, T.E. & BLOOM, S.R. (1984). Radioimmunoassay of Neuropeptide Y. Regul. Peptides, 8, 61-70.
2. BECK, B. (2000). Neuropeptides and obesity. Nutrition, 16, 916-923.
3. BILLINGTON, C.J., BRIGGS, J.E., HARKER, S., GRACE, M. & LEVINE, A.S. (1994). Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am. J. Physiol., 266, R1765-R1770.
4. BINA, K.G. & CINCOTTA, A.M. (2000). Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology, 71, 68-78.
5. BRUNETTI, L., DI NISIO, C., ORLANDO, G., FERRANTE, C. & VACCA, M. (2005). The regulation of feeding: a cross talk between peripheral and central signalling. Int. J. Immunopathol. Pharmacol., 18, 201-212.
6. CHOMCZYNSKI, P. & SACCHI, N. (1987). Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
7. CHU, P.C., LIN, M.T., SHIAN, L.R. & LEU, S.Y. (1986). Alterations in physiologic functions and brain monoamine content in streptozotocin-diabetic rats. Diabetes, 35, 481-485.
8. CINCOTTA, A.H. & MEIER, A.H. (1995). Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus). Metabolism, 44, 1349-1355.
9. COOPER, S.J. & AL-NASER, H.A. (1993). D1:D2 dopamine receptor interactions in relation to feeding responses and food intake. In: D1:D2 Dopamine Receptor Interactions, ed. Waddington, J. pp. 203-234. San Diego: Academic.
10. DRYDEN, S., FRANKISH, H.M., WANG, Q. & WILLIAMS, G. (1996). Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine. Brain Res., 724, 232-237.
11. FRANKISH, H.M., DRYDEN, S., HOPKINS, D., WANG, Q. & WILLIAMS, G. (1995). Neuropeptide Y, the hypothalamus and diabetes: Insights into the control of metabolism. Peptides, 16, 757-771.
12. GILLARD, E.R., DANG, D.Q. & STANLEY, B.G. (1993). Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Brain Res., 628, 128-136.
13. GROVE, K.L. & SMITH, M.S. (2003). Ontogeny of the hypothalamic neuropeptide Y system. Physiol. Behav., 79, 47-63.
14. HEISLER, L.K., COWLEY, M.A., TECOTT, L.H., WEI, F., LOW, M.J., SMART, J.L., RUBINSTEIN, M., TATRO, J.B., MARCUS, J.N., HOLSTEGE, H.L., CHARLOTTE, E., CONE, R.D. & ELMQUIST, J.K. (2002). Activation of central melanocortin pathways by fenfluramine. Science, 297, 609-611.
15. HSIEH, Y.S., YANG, S.F. & KUO, D.Y. (2005). Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum. Regul. Peptides, 127, 169-176.
16. JACKSON, D.M., ROSS, S.B. & HASHIZUME, M. (1988). Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice. Psychopharmacology, 94, 321-327.
17. JETTON, T.L., LIANG, Y. & CINCOTTA, A.H. (2001). Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice. Metabolism, 50, 1377-1384.
18. KALRA, S.P. & KALRA, P.S. (2004). NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides, 38, 201-211.
19. KOTZ, C.M., BRIGGS, J.E., GRACE, M.K., LEVINE, A.S. & BILLINGTON, CJ. (1998). Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat. Am. J. Physiol., 275, R471-R477.
20. KRASZEWSKI, K.Z. & CINCOTTA, A.M. (2000). Increased responsiveness of ventromedial hypothalamic neurons to norepinephrine in obese versus lean mice: relation to the metabolic syndrome. Int. J. Mol. Med., 5, 349-355.
21. KRUGEL, U., SCHRAFT, T., KITTNER, H., KIESS, W. & ILLES, P. (2003). Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur. J. Pharmacol., 482, 185-187.
22. KUO, D.Y. (2003). Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression. Behav. Brain Res., 147, 149-155.
23. KUO, D.Y. (2005). Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats. Regul. Pepticles, 127, 19-26.
24. LEGER, L., CHARNAY, Y., DANGER, J.M., VAUDRY, H., PELLETIER, G., DUBOIS, P.M. & JOUVET, M. (1987). Mapping of neuropeptide Y-like immunoreactivity in the feline hypothalamus and hypophysis. J. Comp. Neurol., 255, 283-292.
25. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with folin phenol reagent. J. Biol. Chem., 193, 265-275.
26. LUO, S., LIANG, Y. & CINCOTTA, A.H. (1999). Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose- intolerant state in hamsters. Neuroendocrinology, 69, 160-166.
27. MISSALE, C., NASH, S.R., ROBINSON, S.W., JABER, M. & CARON, M.G. (1998). Dopamine receptors: from structure to function. Physiol. Rev., 78, 189-225.
28. MORRIS, B.J. (1989). Neuronal localization of neuropeptide Y gene expression in rat brain. J. Comp. Neurol., 290, 358-368.
29. RAMAKRISHNAN, R., KEMPURAJ, D., PRABHAKARAN, K., JAYAKUMAR, A.R., DEVI, R.S., SUTHANTHIRARAJAN, N. & NAMASIVAYAM, A. (2005). A short-term diabetes induced changes of catecholamines and p38-MAPK in discrete areas of rat brain. Life Sci., 77, 1825-1835.
30. RICHARD, D. (1995). Exercise and the neurobiological control of food intake and energy expenditure. Int. J. Obes., 19, S73-S79.
31. SAHU, A., SNINSKY, C.A., PHELPS, C.P., DUBE, M.G., KALRA, P.S. & KALRA, S.P. (1992). Neuropeptide Y release from the paraventricular nucleus in association with hyperphagia in streptozocin-induced diabetic rats. Endocrinology, 131, 1979-1985.
32. SAMANIN, R. & GARATTINI, S. (1993). Neurochemical mechanism of action of anorectic drugs. Annu. Rev. Pharmacol. Toxicol., 73, 63-68.
33. SCISLOWSKI, P.W., TOZZO, E., ZHANG, Y., PHANEUF, S., PREVELIGE, R. & CINCOTTA, A.H. (1999). Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists. Int. J. Obes. Relat. Metab. Disord., 23, 425-431.
34. SIBLEY, D.R. & MONSMA, F.J. (1992). Molecular biology of dopamine receptors. Trends Pharmacol. Sci., 13, 61-69.
35. SINDELAR, D.K., MYSTKOWSKI, P., MARSH, D.J., PALMITER, R.D. & SCHWARTZ, M.W. (2002). Attenuation of diabetic hyperphagia in neuropeptide Y-deficient mice. Diabetes, 51, 778-783.
36. TRULSON, M.E. & HIMMEL, C.D. (1983). Decreased brain dopamine synthesis rate and increased (3H)spiroperidol binding in streptozotocin-diabetic rats. J. Neurochem., 40, 1456-1459.
37. WILLIAMS, G., GILL, J.S., LEE, Y.C., CARDOSO, H.M., OKPERE, B.E. & BLOOM, S.R. (1989). Increased neuropeptide Y concentrations in the specific hypothalamic regions of the streptozocin induced diabetic rats. Diabetes, 38, 321-327.
38. WOODS, S.C., FIGLEWICZ, D.P., MADDEN, L., PORTE JR, D, SIPOLS, A.J. & SEELEY, R.J. (1998). NPY and food intake: discrepancies in the model. Regul. Peptides, 75, 403-408.